Articles | Volume 10, issue 5
https://doi.org/10.5194/jbji-10-363-2025
https://doi.org/10.5194/jbji-10-363-2025
Review
 | 
10 Oct 2025
Review |  | 10 Oct 2025

Serum inflammatory markers for the screening and diagnosis of periprosthetic joint infection: a systematic review and meta-analysis

Irene K. Sigmund, Matthew J. Dietz, Marta Sabater-Martos, Antony J. R. Palmer, Nicolas Cortés-Penfield, and the “Serum Marker Workgroup” for the Unified PJI Definition Taskforce

Viewed

Total article views: 1,824 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
1,066 687 71 1,824 41 34 60
  • HTML: 1,066
  • PDF: 687
  • XML: 71
  • Total: 1,824
  • Supplement: 41
  • BibTeX: 34
  • EndNote: 60
Views and downloads (calculated since 10 Oct 2025)
Cumulative views and downloads (calculated since 10 Oct 2025)

Viewed (geographical distribution)

Total article views: 1,811 (including HTML, PDF, and XML) Thereof 1,811 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 

Cited

Latest update: 25 May 2026
Download
Short summary
Serum C-reactive protein, fibrinogen, and interleukin-6 show the best performance among serum markers for diagnosing periprosthetic joint infection (PJI), but they lack sufficient accuracy to confirm or exclude infection reliably. These markers should be re-evaluated in future PJI definitions, as they are not suitable as stand-alone tests. Given their limitations and the superior diagnostic performance of synovial markers, the role of serum markers in PJI diagnosis should be reconsidered.
Share